藏格礦業(000408.SZ):氯化鉀價格主要以到站價銷售,目前為2850-3100元
格隆匯6月5日丨藏格礦業(000408.SZ)舉行業績説明會,就“請問6月氯化鉀出廠價格是多少?請問榮昌參股公司投資200億是否確有其事?公司是否近期有融資打算?”
公司回覆稱,公司氯化鉀價格主要以到站價銷售,目前為2850-3100元。隨着公司五年發展戰略規劃的實施,公司投資資金需求增大,鑑於公司目前比較低的資產負債率,在合適時機不排除進行適當的債務融資。
公司全資子公司藏格礦業投資(成都)有限公司出資12,000萬元、持股40%,與重慶瑜瀚電子科技有限公司共同投資成立重慶駿力新能源科技有限公司(以下簡稱“重慶駿力公司”),為公司的參股公司;重慶駿力公司與重慶榮昌區政府在榮昌共同建設“榮昌川渝合作新能源產業園項目”,項目總用地面積約1,500畝,該產業園未來擬引進相關產業,重慶駿力公司負責具體招商、運營管理和服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.